Studies on Tumors of the Thyroid
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study ID
- NCT00001160
- Status
- Recruiting
Conditions
- Follicular Thyroid Cancer
- Hurthle Cell Thyroid Cancer
- Papillary Thyroid Cancer
- Tall Cell Variant Thyroid Cancer
- Thyroid Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Months - 98 Years
- Healthy Volunteers
- Not accepted
Interventions
- 68-Gallium Dotatate — DRUGFor evaluation risk/benefit evaluation
Study Details
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies.
Key Dates
- Start date
- Jun 1, 1977
- Status verified
- May 2026
Study Design
- Enrollment
- 2,500 participants (estimated)
Arms
- Arm: thyroid cancerPatients with thyroid cancer
- Arm: thyroid nodulesPatients with thyroid nodules
Primary Outcome Measure
Evaluation of thyroid cancer [ Time Frame: As clinically indicated ]
Central Contacts
- Padmasree Veeraraghavan, R.N.(301) 451-7710
- Joanna Klubo-Gwiezdzinska, M.D.(301) 496-5052
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
Find similar trials in Bethesda, MD
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Personalized Treatment in Thyroid DisordersRecruiting · Johns Hopkins University · Baltimore, Maryland
- The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid CancerPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid CancerPHASE1/PHASE2 · Not Yet Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland